Cash and Cash Equivalents, at Carrying Value of Caris Life Sciences, Inc. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Caris Life Sciences, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • Caris Life Sciences, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2025 was $796,274,000, a 1145% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $796,274,000 +$732,324,000 +1145% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $753,221,000 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $718,934,000 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q4 2024 $63,950,000 31 Dec 2024 10-K 03 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.